Early research (Phase 1)Study completedNCT01656018
What this trial is testing
Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Who this might be right for
Healthy
Janssen Research & Development, LLC 4